Urology

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Billips BK et al. - NU14 delta-waaL is a candidate live-attenuated vaccine for the treatment and prevention of acute and recurrent urinary tract infection by caused by uropathogenic E. coli.

Related Articles

Urinary tract infections in pediatric renal transplant recipients
Pediatric Transplantation, 11/06/09    Relevance Score: 84%

Hygiene and urinary tract infections after cystectomy in 452 Swedish survivors of bladder cancer
BJU International, 11/02/09    Relevance Score: 84%

Serum Procalcitonin for Prediction of Renal Parenchymal Involvement in Children with Urinary Tract Infections
The Journal of Pediatrics, 11/02/09    Relevance Score: 84%

Prevalence of lower urinary tract infection in South Indian type 2 diabetic subjects
Indian Journal of Nephrology, 10/16/09    Relevance Score: 84%

Automated Microscopy, Dipsticks and the Diagnosis of Urinary Tract Infection
BMJ - Archives of Diseases in Childhood, 10/30/09    Relevance Score: 80%